Risk of Infection and Duration of Protection after the Booster Dose of the Anti-SARS-CoV-2 Vaccine BNT162b2 among Healthcare Workers in a Large Teaching Hospital in Italy: Results of an Observational Study. - Pascucci D; Grossi A; Lontano A; Marziali E; Nurchis MC; Grassi VM; Raponi M; Vetrugno G; Capelli G; Calabrò GE; Staiti D; Sanguinetti M; et al. (Vaccines, 2022)